RxDoctor Payments Data

Patrick Chargot, DO

Obstetrics & Gynecology · Fort Payne, ALNPI 1356907000

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $630 of the $814 with a category attached, or 77.4%. 17 manufacturers reported payments, led by Astellas Pharma US Inc at 39.6% of the total. 2025 is the largest year on record at $336, more than ten times the $21 reported in 2020. That places this record below the midpoint for obstetrics & gynecology clinicians in AL, where the typical reported total is $1,456.

$814in general payments, 2019–2025

Across 31 payments — averaging $26.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$323
  • Convatec Inc.$99
  • Therapeuticsmd, Inc.$90
  • Minerva Surgical, Inc$48
  • Shield Therapeutics Inc$37
  • Corium, LLC$27
  • plus $190 from 11 others

What the payments were for

  • Food & beverage$63077%
  • Education$18423%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$814 in reported general payments places this provider in the 30th percentile of 537 obstetrics & gynecology providers in Alabama.

See all obstetrics & gynecology providers in Alabama →

Medicare billing

Part B allowed, 2024
$6,642
Medicare patients
69
Services billed
118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol41$2,236
Raloxifene Hcl11$257

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Fort Payne

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →